In our study, PCSK9 concentrations did not correlate with liver enzymes, similarly like in Wargny et al.'s study, nor with CK-18 fragments, a marker of NAFLD [45]. The gene discussed is PCSK9; the disease is metabolic dysfunction-associated steatotic liver disease.